Bundamedik Tbk PT
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, medical tourism, and dental clinic services management consulting businesses. It al… Read more
Bundamedik Tbk PT (BMHS) - Total Assets
Latest total assets as of September 2025: Rp3.64 Trillion IDR
Based on the latest financial reports, Bundamedik Tbk PT (BMHS) holds total assets worth Rp3.64 Trillion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bundamedik Tbk PT - Total Assets Trend (2018–2024)
This chart illustrates how Bundamedik Tbk PT’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bundamedik Tbk PT - Asset Composition Analysis
Current Asset Composition (December 2024)
Bundamedik Tbk PT's total assets of Rp3.64 Trillion consist of 31.6% current assets and 68.4% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 8.6% |
| Accounts Receivable | Rp174.76 Billion | 5.1% |
| Inventory | Rp47.02 Billion | 1.4% |
| Property, Plant & Equipment | Rp2.03 Trillion | 58.9% |
| Intangible Assets | Rp0.00 | 0.0% |
| Goodwill | Rp94.79 Billion | 2.8% |
Asset Composition Trend (2018–2024)
This chart illustrates how Bundamedik Tbk PT's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bundamedik Tbk PT's current assets represent 31.6% of total assets in 2024, an increase from 17.5% in 2018.
- Cash Position: Cash and equivalents constituted 8.6% of total assets in 2024, up from 8.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is property, plant & equipment at 58.9% of total assets.
Bundamedik Tbk PT Competitors by Total Assets
Key competitors of Bundamedik Tbk PT based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Bundamedik Tbk PT - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Bundamedik Tbk PT generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Bundamedik Tbk PT generates $ 0.35 in net profit.
Bundamedik Tbk PT - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.96 | 1.76 | 1.19 |
| Quick Ratio | 1.89 | 1.70 | 1.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp567.11 Billion | Rp 618.19 Billion | Rp 132.52 Billion |
Bundamedik Tbk PT - Advanced Valuation Insights
This section examines the relationship between Bundamedik Tbk PT's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.13 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 11.8% |
| Total Assets | Rp3.45 Trillion |
| Market Capitalization | $23.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bundamedik Tbk PT's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Bundamedik Tbk PT's assets grew by 11.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bundamedik Tbk PT (2018–2024)
The table below shows the annual total assets of Bundamedik Tbk PT from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp3.45 Trillion | +11.78% |
| 2023-12-31 | Rp3.08 Trillion | +4.92% |
| 2022-12-31 | Rp2.94 Trillion | +9.34% |
| 2021-12-31 | Rp2.69 Trillion | +24.28% |
| 2020-12-31 | Rp2.16 Trillion | +54.38% |
| 2019-12-31 | Rp1.40 Trillion | +12.86% |
| 2018-12-31 | Rp1.24 Trillion | -- |